Aurobindo Pharma reported INR339.59B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Cipla INR 250.61B 9.14B Sep/2026
Divis Laboratories Ltd INR 124.39B 13.43B Sep/2026
Dr.Reddys Laboratories INR 297.32B 2.01B Sep/2026
Hindustan Unilever INR 221.34B 31.13B Sep/2026
Sun Pharmaceuticals INR 692.67B 54.06B Sep/2026
UPL INR 475.77B 52.82B Sep/2026